THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (AMGN) today announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of Repatha ® (evolocumab) to include ...
NEW YORK, N.Y. (WPVI) -- For people fighting high cholesterol, a new study on the drug Repatha offers good news and bad news. On the up side, 2 years of taking Repatha along with conventional statins ...
A cholesterol-cutting drug from Amgen succeeded in lowering patients’ risk of cardiovascular trouble in a huge clinical trial — but the results, announced Friday, may not be good enough to prompt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback